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ioninvasive Detection of
ulnerable Plaques
re We There Yet?
e read with great interest the study by Motoyama et al. (1)
emonstrating that patients with low-attenuation and positively
emodeled plaques—as detected by computed tomography angiog-
aphy (CTA)—were more likely to suffer from acute coronary
yndromes (ACS) during follow-up. A total of 10,037 coronary
egments 2 mm in diameter were analyzed in 1,059 patients;
fter a follow-up 2 years, 15 of these patients suffered ACS.
dverse CTA features (remodelling and/or low attenuation) were
owerful predictors of ACS development after adjustment (hazard
atio: 22.8). This study is provocative indeed, considering that, up
o now, the diagnosis of vulnerable plaque (VP) (defined as those
t higher risk for future rupture/thrombosis) has been elusive (2).
n fact, despite the use of sophisticated and highly accurate
ntracoronary diagnostic techniques (intravascular ultrasound, vir-
ual histology, elastography, thermography, coronary angioscopy,
nd optical coherence tomography) the identification of VP has
een not only a moving target but also clinically unreliable (2–5).
urrently, with invasive techniques, unique insights on plaque
haracteristics including morphology, composition, physiologic
roperties, and even measurements of local temperature, macro-
hage content and fibrous cap thickness can be obtained; yet we
annot accurately predict their prognosis (2–5).
Addressing some methodological issues would be highly appre-
iated, considering the potential major implications of the present
tudy (1). First, data confirming that the detected ACS were in fact
elated to the coronary segment presenting adverse CTA features
eems crucial. Therefore, electrocardiographic or angiographic
ndings correlating ACS episodes with the target vessel/lesion
ould be reassuring. Conversely, if events arose from other
oronary segments, the information would be difficult to interpret.
his is particularly worrisome, considering the study definition of
CS (troponin rise was not required) and that up to 651 segments
excluded from CTA analysis) had previous/scheduled coronary
nterventions. Second, all patients had established or suspected
oronary artery disease; however, information on clinical presen-
ation (asymptomatic, stable angina, stabilized unstable angina)
ould be of relevance to better define the population risk profile.
hird, only 45 patients (4.5%) presented plaques with both
ttenuation and positive remodelling. Nevertheless, in similar
atient cohorts, intravascular ultrasound studies frequently detect
ultiple nonocclusive plaques with low-echogenicity or significant
ecrotic cores, associated with positive remodelling (2–5). Accord-
ngly, additional explanations on CTA plaque characterization
ould be of value to reconcile these apparent discordant results.
ourth, up to 22% of patients harboring plaques with both adverse
ndings suffered ACS; this is a striking figure, considering the
elatively low-risk patient population analyzed. Finally, we should ieep in mind that ACS emerge from heterogeneous substrates.
rosion of fibrotic plaques, calcified nodules, and intra-plaque
emorrhage are well-recognized underlying substrates of ACS all
acking the distinct morphologic features of thin-cap fibroathe-
oma (2).
We fully agree with the authors’ suggestion that additional
tudies are required to demonstrate the value of CTA to identify
he “highly elusive” VP. If the value of CTA to accurately identify
igh-risk plaques is confirmed (possibly with the additional help of
ystemic biomarkers), the dawn of a new era—namely that of
pplying aggressive preventive interventions (intensive systemic
herapy or intracoronary stenting) to “passivate” these plaques—
ill undoubtedly begin.
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e thank Dr. Alfonso for interest in our manuscript and very
nsightful comments. We agree that feasibility of noninvasive identi-
cation of plaques vulnerable to rupture might have significant clinical
mplications, and clarify here the methodological issues raised. As
escribed in our paper (1), acute coronary syndromes (ACS)
ncluded acute myocardial infarction with the elevation of troponin
evel and unstable angina without troponin elevation. Our report
haracterized the plaques that resulted in ACS and excluded the
esions already subjected to intervention or those selected for
ntervention. As noted in the report, 3 patients developed ACS
nvolving the previously treated lesion and were excluded from the
